Introduction: Cardiovascular disease is the leading cause of death in women.
| INTRODUC TI ON
Cardiovascular disease (CVD) is the leading cause of death in women in the Western world.
1 Women have a unique risk profile for CVD compared with men. 2 Pregnancy can be considered a "stress test"
unmasking underlying cardiovascular defects. 3 A history of gestational diabetes, preeclampsia or pregnancy-induced hypertension is mentioned as a major risk factor in women for developing CVD in the American Heart Association Guidelines. 2 Miscarriages are not considered in that guideline.
Recurrent miscarriage (RM) is commonly defined as 3 or more consecutive pregnancy losses before 22 weeks of gestation 4 and affects 0.5%-3% of all fertile couples. 5 Observational studies suggest that women with a history of RM also have an increased risk of CVD. [6] [7] [8] [9] Several hypotheses are possible for the association between both diseases; shared common risk factors such as obesity and smoking, 10 endothelial dysfunction, 11 and a genetic predisposition is assumed.
12
We hypothesize that women with a history of RM have a more unfavorable cardiovascular risk profile already at a young age compared with women with no miscarriage. If so, women with RM represent an ideal target population for preventive strategies. Worldwide multivariable risk assessment tools have been developed to detect apparently healthy individuals at high risk for CVD. 13 At present the most common externally validated risk model is the Framingham risk score.
14 A follow-up study was conducted to determine cardiovascular risk factors and predict the long-term CVD risk using Framingham risk scores in women with a history of RM.
| MATERIAL AND ME THODS

| Study design
Follow-up study.
| Exposed
Women who visited the RM clinic at Leiden University Medical
Center between 2000 and 2010 and had their third consecutive miscarriage below the age of 31 years were invited to participate in this follow-up study. RM was defined as ≥3 consecutive miscarriages before 22 weeks of gestation. All women had a routine RM 
| Unexposed
Women with one or more uncomplicated pregnancy(ies) and no miscarriages were enrolled (reference group). In the Netherlands, it is common practice that independent community midwives take care of low-risk women (with no medical or obstetrical history) during pregnancy and childbirth. The zip code of each woman with RM was used to contact the nearest midwifery practice to take the impact of socioeconomic status into account. Women with the same zip code and the same age (difference in birth date a maximum of 1 year) and for whom the time of first delivery was close to the time of the third miscarriage of the matched exposed woman (maximum 6 months before or 6 months after)
were asked to participate. Women with RM were included in the study before the matched controls were invited to participate; a small difference in follow-up time was therefore expected.
In both groups, pregnant and lactating women (within the last 3 months) were excluded. Enrollment took place between 2012 and 2014.
| Procedures and definitions
After enrollment, all women were asked to fill out a web-based questionnaire and were invited for risk factor screening. by the homeostasis model assessment. 22 The blood samples were centrifuged, separated, and frozen at −80°C within 2 hours.
Routine chemistry analyses were performed on a Roche Modular P800 chemistry analyzer using reagents of Roche Diagnostics The 10-and 30-year CVD risk by the Framingham score 23, 24 was calculated using information on age, systolic blood pressure, antihypertensive treatment, smoking, diabetes, and lipid spectrum (total cholesterol and HDL cholesterol) or BMI (a simpler model of the risk score). Both models, using lipids and using BMI, were applied. CVD was defined as coronary death, myocardial infarction, coronary insufficiency, angina pectoris, ischemic stroke, hemorrhagic stroke, transient ischemic attack, peripheral artery disease, or heart failure. The 10-year CVD risk score was calculated twice, once using current age and subsequently estimating the risk as if the woman was 60 years of age (due to the young age of our participants, the estimated absolute 10-year CVD risk was likely to be low). This approach has been recommended in the cardiovascular risk factor management guidelines for young women with elevated risk factor levels. 25 The risk estimation was repeated in a subgroup analysis including women with idiopathic RM. RM was defined as idiopathic when the work-up for causes of RM showed no abnormalities.
| Sample size considerations
The calculation was based on results of the Hyras study: the (extrapolated) 10-year CVD risk was 4.4% (SD 1.9) in women with uncomplicated pregnancies. 26 We planned to include women in 1:1 ratio, that is, a woman who had RM matched to one control. A relative risk of 1.5 or higher was considered to be clinically relevant. A sample size of 68 women (34 exposed, 34 non-exposed) was sufficient, with a 10% drop-out rate (two-sided alpha .05. power 90%). 
| Statistical analyses
| Ethical approval
Approval from the medical ethics committee of Leiden University
Medical Center (P04-020; 3 October 2012) was obtained and all participants gave informed consent. The study was registered with the Dutch trial registry NTR3408. This study is part of the REMI (REcurrent MIscarriages) studies, studies which investigate consequences and causes of RM.
| RE SULTS
A flowchart of the inclusion of the participants is shown in Figure 1 .
Thirty-six matched pairs were included.
Women with RM had a significantly higher gravidity and lower parity than those in the no miscarriage group (Table 1) . Women with RM were more often smokers during pregnancy (P = .05). On all other variables, groups were comparable.
Of the women with RM (n = 28), 78% were diagnosed with idiopathic RM. Parental chromosomal abnormality was found in 1 case, antiphospholipid syndrome in 1 case, hyperhomocysteinemia in 3 cases, and heritable thrombophilia in 3 cases.
Mean follow-up time was 6.8 years (SD 3.0) in women with RM and 8.1 years in women with no miscarriage (SD 2.9), (P < .001).
Classical cardiovascular risk factors are described in Table 2 . Women with RM were slightly younger at time of follow-up than women with no miscarriage (P < .001). Values of classical cardiovascular risk factors were higher in women with RM compared with women no miscarriage, although the values were only significant for systolic blood pressure.
Women with RM had significantly higher mean CVD risk scores compared with women with no miscarriage (Table 3) , whether using the lipids or the BMI model. In the subgroup analysis including women with idiopathic RM, comparable results to those of the total group were found (Table 3) .
| D ISCUSS I ON
In this follow-up study, an increased (extrapolated) 10-and 30-year The Framingham risk score is the most externally validated risk score and is widely used in North American countries. 14 It is the only model which can estimate the 10-and 30-year CVD risk (mortality and morbidity) and is therefore useful to estimate risks for a young population. European guidelines advise using SCORE, which assesses only mortality risk and therefore is less useful in our young population. 27 Overestimation of the risk of CVD is possible using the Framingham score in a European cohort.
14 If so, an overestimation of the risk occurred in both groups and therefore would not change the direction of effect. Due to the young age of our participants, we calculated the 10-year risk scores as if the women were 60 years of age according to guidelines for young women with elevated risk factor levels. 25 The new method of "cardiovascular risk age" 28 was not applicable to our young cohort (age below 40 years). A disadvantage of this method, extrapolating to an age of 60 years, is that the real risk could be underestimated, assuming that levels of cardiovascular risk factors will increase without prevention or intervention. Perhaps this is why we found quite a large difference between the extrapo- women with preexisting markers of endothelial dysfunction, introducing a high level of selection bias. The explanation for this is that they were investigating the hypothesis that endothelial dysfunction could be the link between miscarriage and CVD. We performed a subgroup analysis including only women with idiopathic RM (n = 28) (Table 3) , which showed comparable results to the results of the total group. Therefore, in the present study, the increased risk of CVD in women with RM cannot be explained by the presence of known acquired and heritable thrombophilia.
In Table 2 , we described the individual classical risk factors. Only systolic blood pressure was significantly higher in women with RM No miscarriage n = 36
Non-responders n = 52
Declined to participate due to emotional reasons n = 17
Did not meet inclusion criteria (> 30 years, pregnant/lactating during study period) n = 3
Non-responders n = 56
Declined to participate n = 44
No miscarriage n = 38
Did not meet inclusion criteria (pregnant/lactating during study period) n = 10
No miscarriage, n = 36 
TA B L E 2 Classical cardiovascular risk factors
compared with those with no miscarriage. Since we did not perform a sample size analysis based on individual risk factors, a lack of power is likely when investigating the individual risk factors. It would be interesting to investigate these risk factors in a larger study group. As we were only able to look at cardiovascular risk factors in women after they experienced RM, we cannot answer the question about cause and effect. Although preexisting CVD risk factors are associated with an increased risk of developing miscarriages, it is not known whether miscarriages merely unmask risk or contribute directly to future CVD. Miscarriages could trigger a pathophysiological mechanism or cascade that in turn leads to CVD, potentially via interactions with classical risk factors.
To our knowledge this is the first study which investigated and calculated CVD risk scores in women with a history of RM. A strength of our research is the unique, well-defined cohort. RM is a highly heterogenic condition; to strive for more homogeneity, in the present study we only included women who had their third consecutive miscarriage below the age of 31. A younger age at diagnosis makes a maternal cause of RM more plausible and reduces the chance of miscarriages due to fetal abnormalities. 30 Another strength is the availability of a wide range of covariates in both groups (Table 1) .
Some covariates have an effect on our outcome of interest. It would not make sense to adjust for BMI or smoking as confounding factors, since both are included as variables in the risk estimation. 31 On the other hand, it is interesting to verify whether the increased cardiovascular risk score in women with RM persists after adjustments for smoking and hypertension, or whether the results are totally dependent on these variates. For this reason, we performed multivariate analyses including smoking and hypertension (Tables S1 and S2) ; we found that neither solely explains the increased risk.
Some women experienced a complication during pregnancy such as gestational diabetes and preeclampsia which may increase their risk of CVD later in life. 2, 32 We did not adjust for a history of complications of pregnancy since these events may be on the causal pathway between miscarriage and CVD. 33 If we assume that they are not on this pathway and that these events are confounding factors, we should have adjusted for these pregnancy complications.
Therefore, we repeated the risk calculations for women who did not have a pregnancy complicated by gestational diabetes, preeclampsia, pregnancy-induced hypertension, or preterm birth (Tables S1   and S2 ). Women with RM (n = 30) still had a significantly higher extrapolated 10-year cardiovascular risk score (using lipids: mean 5.31%, SD 3.96) compared with women with no miscarriage (mean 3.59%, SD 1.94, P = .03). Comparable results were found in women with idiopathic RM (n = 24) (Tables S1 and S2 ). Therefore, we can conclude that the elevated risk scores in women with RM cannot be explained solely by other pregnancy complications known to be risk factors in women for developing CVD.
Limitations of our study should be acknowledged. .06
Data are presented as mean (SD).
the "worst" cases, women without a live birth, were more likely to decline or not respond (only 1 woman in our study group had no live birth). Secondly, women received lifestyle advice during their consultations at the RM clinic. Individual risk factors may have been changed, which could decrease the risk profile. Finally, the increased risk could be underestimated because women with RM were included in the study before the matched controls were invited to participate, resulting in a small difference in age (1.2 years) at follow up, and risk factors are likely to increase with age. On the other hand, since the unexposed group consisted of women who had at least 1 uncomplicated pregnancy, this may have resulted in a healthier cohort compared with a population-based cohort.
Selection bias is also possible in the unexposed group; women with a higher education are probably more likely to participate (although no significant difference was found for university-level education between both groups). Another limitation is the relatively small sample size. A preliminary calculation was performed based on the 10-year risk score with age extrapolated to 60 years, which showed that 34 women in both groups would be sufficient.
However, it is possible that, especially for the subgroup analyses, our study may be partly underpowered, and we should be cautious about drawing conclusions.
| CON CLUS ION
In the present study, we show that women with a history of RM, whether idiopathic or not, differ in cardiovascular risk profile at a young age compared with women with no miscarriage. Our study provides intriguing data which support the need for more research to find out whether women with a history of RM should be offered screening and counseling for cardiovascular risk factors.
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